Calcium antagonists in clinical medicine /
Saved in:
| Edition: | 2nd ed. |
|---|---|
| Imprint: | Philadelphia : Hanley & Belfus, c1998. |
| Description: | xviii, 590 p. : ill. ; 24 cm. |
| Language: | English |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/3787890 |
Table of Contents:
- Basic Principles
- 1. Mechanisms of Action of Calcium Antagonists
- 2. Alterations in Cardiovascular Cation Metabolism in the Cardiometabolic Syndrome
- 3. Endothelial Regulation of Vascular Tone and Growth: Role of Calcium Antagonists
- 4. Endothelial Dysfunction: Evolving Perspectives for Pathogenesis & Calcium Antagonist Therapy
- Clinical Pharmacology
- 5. Pharmacokinetics of Calcium Antagonists: Implications for Therapy
- 6. Calcium Antagonists and the Cytochrome P450 System
- 7. Time-Effect Profile and Duration of Action of Calcium Antagonists: Implications for Rational Management
- 8. Ambulatory Blood Pressure Monitoring in the Evaluation ofAntihypertensive Treatment with Calcium Antagonists
- 9. Controlled-Release Formulations of the Calcium Antagonists
- 10. Novel Therapeutic Applications for Calcium Antagonists: Atherosclerotic Plaque Stabilization
- Metabolic Effects
- 11. Insulin and Glucoregulatory Hormones: Implications for Antihypertensive Therapy
- 12. Effects of Calcium Antagonists on Lipids
- The Heart
- 13. Effect of Calcium Antagonists on Hemodynamics, Left Ventricular Mass and Myocardial Flow Reserve
- 14. Cardiac Effects of Calcium Antagonists in Hypertension
- 15. Calcium Antagonists and Myocardial Ischemia
- 16. The Therapeutic Potential of Calcium Antagonists for Lethal Ventricular Arrhythmias: Ischemia-selective Antagonists May Prevent Ventricular Fibrillation
- 17. The Clinical Antiarrhythmic Effectiveness of Calcium Antagonists
- 18. Are Calcium Antagonists Proarrhythmic?
- Hypertension
- 19. Calcium Antagonists in the Management of Hypertension
- 20. Hemodynamic Effects of Calcium Antagonists in Hypertension
- 21. Systolic Blood Pressure and Pulse Pressure as Determinants of Cardiovascular Risk: Implications for Rational Therapy
- 22. Arterial Compliance and Effect of Calcium Antagonists
- 23. The Role of Calcium Antagonists in Cardiovascular Prevention: A Meta-analysis of Recent Trials
- Special Populations
- 24. Diabetic Nephropathy: Focus on the Renin-Angiotensin System and Calcium Channel Blockade
- 25. Calcium Antagonists: Are They All Created Equal in Regard to Slowing Progression of Diabetic Nephropathy?
- 26. Calcium Antagonists as Antihypertensive Agents in African-American Patients
- 27. Drug Responsiveness and Side Effects: Lessons from Chinese Populations
- 28. Pharmacogenetic Markers of Hypertension: Pathogenesis and Responses to Therapy
- 29. Calcium Antagonists in Elderly Patients with Systemic Hypertension
- 30. Management of High Blood Pressure in Pregnancy
- Calcium Antagonists In The Treatment Of Noncardiovascular Disorders
- 31. Calcium Antagonists and Central Nervous System Diseases
- Calcium Antagonists And The Kidney
- 32. Renal Hemodynamic Effects of Calcium Antagonists
- 33. Effects of Calcium Antagonists on Vasoactive Hormones
- 34. The Clinical Utility of Calcium Antagonists in Renal Transplant Recipients
- 35. Calcium Antagonists and the Kidney; Implications for Renal Protection
- 36. Ambulatory Blood Pressure: Implications for Renal Dysfunction
- 37. Salt Sensitivity and Microalbumuria: Implications for Pathogenesis and Management
- 38. Calcium Antagonists and End-Stage Renal Disease: Pharmacokinetics and Pharmacodynamics
- Emerging Perspectives
- 39. Fixed-dose Combination Therapy with Calcium Antagonists
- 40. Inproving the Cost-effectiveness of Treating Hypertension
- 41. Effects of Calcium Antagonists on Atherosclerosis
- 42. Sympathoinhibitory and Sympathoexcitatory Effects of Dihydropyridine Calcium Antagonists
- 43. Apoptosis and Risk with the Use of Calcium Antagonists
- 44. Safety of Calcium Antagonists as Antihypertensive Agents: An Update
